End-of-day quote
Other stock markets
|
||
- USD | - |
2014 | Cubist Pharmaceuticals : sales force seen as potential boon for Merck intestinal drug | RE |
2014 | Cubist Pharmaceuticals : Merck says still plans to buy Cubist, despite patent setback | RE |
Managers | Title | Age | Since |
---|---|---|---|
Karen Rogers
PRN | Corporate Officer/Principal | - | - |
Sales & Marketing | - | - | |
Corporate Officer/Principal | - | 96-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 70 | 06-08-31 | |
Director/Board Member | 70 | 13-09-24 |
1st Jan change | Capi. | |
---|---|---|
-2.61% | 88.47B | |
+3.55% | 40.71B | |
-13.92% | 32.43B | |
+54.88% | 24.28B | |
-15.25% | 15.52B | |
-41.29% | 12.17B | |
-14.80% | 12.01B | |
-11.75% | 12B | |
+7.49% | 8.87B |
- Stock Market
- Equities
- Stock